Abstract Submission


The next AAS meeting is scheduled for November 6-9, 2024.

Selected abstracts will be published in a special edition of Clinical Autonomic Research.

During the submission process, you will have the opportunity to select your preferred presentation method: Oral Platform and/or Poster. Others will have the opportunity to present their Poster, answer questions, and interact with attendees.

Submission of an abstract to #AAS2024 is a commitment on the part of the presenting author to participate in the meeting and present the abstract if it is accepted for presentation.


Significance of the hypothesis

Rigor of the methods and approach

Significance and potential impact of the findings

Validity of conclusion(s)

Presentation quality of the submission


  • Maximum 350 words (excluding title, authors, affiliations, and funding).

  • Figures and tables are not allowed.

  • Prepare your abstract body (including title, authors, affiliations, funding) in an MS Word document.

  • You will be asked to cut and paste the text of your abstract into the online program.

  • Abstracts describing human research with 3 or more subjects will require appropriate IRB (or equivalent) approval and abstracts involving animal research will require appropriate IACUC (or equivalent) approval. Abstracts without such approvals cannot be accepted.

  • Abstract submission is FREE!

  • Authors need not be AAS members nor be sponsored by a member. Acceptances will be based solely on quality.

  • Late Breaking Abstracts: We may accept a limited number of late breaking abstracts. These abstracts are reserved for highly relevant, high impact research whereby the data becomes available after the general abstract submission deadline. This is NOT a deadline extension of the general abstract submission deadline.

Authors will be asked to select their preferred format (poster, platform).

Note: If selected for a platform presentation, CME disclosures will be required from all authors in a timely fashion.